Education
About Us
Working with TipRanks
Follow Us
ATAI Life Sciences (ATAI)
NASDAQ:ATAI
Total Valuation
ATAI Life Sciences has a market cap or net worth of $255.82M. The enterprise value is $109.80M.
Market Cap$255.82M
Enterprise Value$109.80M
Share Statistics
ATAI Life Sciences has 198.31M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding198.31M
Owened by Insiders33.43%
Owened by Instutions2.21%
Financial Efficiency
ATAI Life Sciences’s return on equity (ROE) is -1.28 and return on invested capital (ROIC) is -72.86%.
Return on Equity (ROE)-128.35%
Return on Assets (ROA)-93.65%
Return on Invested Capital (ROIC)-72.86%
Return on Capital Employed (ROCE)-76.39%
Revenue Per Employee$6,129.63
Profits Per Employee-$2,381,537.037
Employee Count54
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of ATAI Life Sciences is -1.43. ATAI Life Sciences’s PEG ratio is >-0.01.
PE Ratio-1.43
PS Ratio0.00
PB Ratio1.83
Price to Fair Value1.83
Price to FCF-2.58
Price to Operating Cash Flow-2.58
PEG Ratio>-0.01
Income Statement
In the last 12 months, ATAI Life Sciences had revenue of $331.00K and earned -$128.60M in profits. Earnings per share was -$0.81.
Revenue$331.00K
Gross Profit$65.00K
Operating Income-$105.88M
Pretax Income-$127.81M
Net Income-$128.60M
EBITDA-121.72M
Earnings Per Share (EPS)-0.81
Cash Flow
In the last 12 months, operating cash flow was -$79.24M and capital expenditures -$11.04K, giving a free cash flow of -$56.68M billion.
Operating Cash Flow-$79.24M
Free Cash Flow-$56.68M
Free Cash Flow per Share-$0.29
Dividends & Yields
ATAI Life Sciences pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-38.70%
Earnings Yield-70.08%
Stock Price Statistics
Beta1.72
52-Week Price Change-37.68%
50-Day Moving Average1.67
200-Day Moving Average1.43
Relative Strength Index (RSI)36.73
Average Volume (3m)1.87M
Important Dates
ATAI Life Sciences upcoming earnings date is May 20, 2025, Before Open.
Last Earnings DateMar 27, 2025
Next Earnings DateMay 20, 2025
Ex-Dividend Date―
Financial Position
ATAI Life Sciences as a current ratio of 3.21, with Debt / Equity ratio of 0.07
Current Ratio3.21
Quick Ratio3.21
Debt to Market Cap0.04
Net Debt to EBITDA0.10
Interest Coverage Ratio32.87
Taxes
In the past 12 months, ATAI Life Sciences has paid $269.00K in taxes.
Income Tax$269.00K
Effective Tax Rate-0.24%
Enterprise Valuation
ATAI Life Sciences EV to EBITDA ratio is -1.98, with an EV/FCF ratio of -2.46.
EV to Sales0.00
EV to EBITDA-1.98
EV to Free Cash Flow-2.46
EV to Operating Cash Flow-2.46
Balance Sheet
ATAI Life Sciences has $44.96M in cash and marketable securities with $23.81M in debt, giving a net cash position of -$21.16M billion.
Cash & Marketable Securities$44.96M
Total Debt$23.81M
Net Cash-$21.16M
Net Cash Per Share-$0.11
Tangible Book Value Per Share$0.71
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for ATAI Life Sciences is $8.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$8.00
Price Target Upside520.16%
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast-0.90%
EPS Growth Forecast-89.51%